Literature DB >> 15338908

Clostridium difficile associated with acute colitis in mature horses treated with antibiotics.

V Båverud1, A Gustafsson, A Franklin, A Lindholm, A Gunnarsson.   

Abstract

Clostridium (C.) difficile, or its cytoxin, was demonstrated in faecal samples from 10 of 25 (40%) mature horses investigated with acute colitis treated primarily with antibiotics for disorders other than diarrhoea. C. difficile was not found in faecal samples from 140 horses without signs of enteric disorders, from 21 nondiarrhoeic horses treated with antibiotics, nor from 22 horses with colitis untreated with antibiotics. Except for C. difficile neither Salmonella nor any other investigated intestinal pathogen was isolated in any of the diarrhoeic horses. The findings strongly support some earlier reports that C. difficile is associated with acute colitis in mature horses treated with antibiotics. Of the 10 horses, 4 proved positive for C. difficile both in culture and in the cytotoxin test, 4 in culture only and 2 only in the cytotoxin test. Eight of 10 horses positive for C. difficile were or had recently been hospitalised, indicating that C. difficile may be a nosocomial infection in horses. All horses positive for C. difficile were treated with beta-lactam antibiotics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 15338908     DOI: 10.1111/j.2042-3306.1997.tb03124.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  12 in total

Review 1.  The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge.

Authors:  E R Dubberke; D B Haslam; C Lanzas; L D Bobo; C-A D Burnham; Y T Gröhn; P I Tarr
Journal:  Zoonoses Public Health       Date:  2010-09-24       Impact factor: 2.702

Review 2.  Bacterial and viral enterocolitis in horses: a review.

Authors:  Francisco A Uzal; Luis G Arroyo; Mauricio A Navarro; Diego E Gomez; Javier Asín; Eileen Henderson
Journal:  J Vet Diagn Invest       Date:  2021-11-11       Impact factor: 1.569

3.  Prevalence of beta2-toxigenic Clostridium perfringens in horses with intestinal disorders.

Authors:  C Herholz; R Miserez; J Nicolet; J Frey; M Popoff; M Gibert; H Gerber; R Straub
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

Review 4.  Clostridium (Clostridioides) difficile in animals.

Authors:  J Scott Weese
Journal:  J Vet Diagn Invest       Date:  2020-01-06       Impact factor: 1.279

5.  Presence and molecular characterization of Clostridium difficile and Clostridium perfringens in intestinal compartments of healthy horses.

Authors:  Angelika Schoster; Luis Guillermo Arroyo; Henry Rolf Staempfli; Patricia Elisabeth Shewen; Jeffrey Scott Weese
Journal:  BMC Vet Res       Date:  2012-06-29       Impact factor: 2.741

Review 6.  Probiotic use in horses - what is the evidence for their clinical efficacy?

Authors:  A Schoster; J S Weese; L Guardabassi
Journal:  J Vet Intern Med       Date:  2014-09-17       Impact factor: 3.333

7.  Identification of risk factors influencing Clostridium difficile prevalence in middle-size dairy farms.

Authors:  Petra Bandelj; Rok Blagus; France Briski; Olga Frlic; Aleksandra Vergles Rataj; Maja Rupnik; Matjaz Ocepek; Modest Vengust
Journal:  Vet Res       Date:  2016-03-12       Impact factor: 3.683

Review 8.  Equine faecal microbiota transplant: Current knowledge, proposed guidelines and future directions.

Authors:  K R Mullen; K Yasuda; T J Divers; J S Weese
Journal:  Equine Vet Educ       Date:  2016-02-28       Impact factor: 1.063

9.  Faecal bacterial composition in horses with and without free faecal liquid: a case control study.

Authors:  Katrin M Lindroth; Johan Dicksved; Erik Pelve; Viveca Båverud; Cecilia E Müller
Journal:  Sci Rep       Date:  2021-02-26       Impact factor: 4.379

10.  Clostridioides (Clostridium) difficile in neonatal foals and mares at a referral hospital.

Authors:  Jeffrey Scott Weese; Nathan Slovis; Joyce Rousseau
Journal:  J Vet Intern Med       Date:  2021-03-03       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.